Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

TNM staging

  • You have access
    Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung Adenocarcinoma
    TOMOYOSHI TAKENAKA, TETSUZO TAGAWA, MIKIHIRO KOHNO, NAOKI HARATAKE, FUMIHIKO KINOSHITA, YUKI ONO, SHO WAKASU, YUKA OKU and MASAKI MORI
    Anticancer Research February 2022, 42 (2) 1137-1142; DOI: https://doi.org/10.21873/anticanres.15577
  • You have access
    Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer
    GABRIEL LIBERALE, SOPHIE VANKERCKHOVE, MARIA GOMEZ GALDON, DENIS LARSIMONT, BISSAN AHMED, FIKRI BOUAZZA, MICHEL MOREAU, ISSAM EL NAKADI, VINCENT DONCKIER, PIERRE BOURGEOIS and R&D Group for the Clinical Application of Fluorescence Imaging at the Jules Bordet Institute
    Anticancer Research September 2016, 36 (9) 4853-4858;
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire